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Urinary incontinence is a prevalent condition affecting an estimated
13 million Americans of which 85% are women. The types of
incontinence as well as their diagnosis and management are pre
sented herein.
Introduction
Urinary incontinence (UI) is defined as the involuntary loss of
urine. Incontinence is a symptom not a disease and is quite common.
The agency for Health Care Policy and Research reported that
approximately 13 million Americans have UI of which 85% are
women.’ The incidence of UI increases with age; however it is not
limited to the elderly. Ten to twenty five percent of women between
age 15 and 64 have UI.’ The societal cost of incontinence in the
United States in 1995 has been estimated to be over 26 billion dollars
for only those patients 65 years and older.2 Incontinence produces
emotional and physical discomfort, often causing individuals to
limit their activities for fear of ridicule or potential loss of self-
esteem and resulting in depression. Despite this, it has been esti
mated that only 10% people with incontinence seek medical help for
their incontinence. Recently, there has been a number of advances
in the diagnosis and management of UI. Health care providers
should be aware of these advances and take an active role in the
diagnosis and management of UI with a goal of decreasing the
impact of this symptom upon our society.
Types of Incontinence
There are several types of incontinence which fall into two basic
functional defects. Either the bladder fails to properly store urine or
the urethra fails to act as an effective sphincter. Bladder causes of UI
include: urge incontinence and overflow incontinence. Urethral
causes include: stress urinary incontinence and instrinsic sphincter
deficiency.
Urge incontinence occurs when the bladder contracts without
permission either with or without warning. Commonly this is
manifested by a person who gets the urge to void but leaks prior to
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reaching the toilet. When urge incontinence is secondary to a
neurological lesion, such as cerebrovascular accident, Alzheimer’ s
disease, or multiple sclerosis, it is known as detrusor hyperreflexia.
Urge incontinence from a non-neurological etiology is known as
detrusor instability.
Overflow incontinence occurs when a full bladder overcomes the
resistance of the urinary sphincter and overflows. This form of UI is
associated with diabetes mellitus or pelvic trauma that disrupts the
normal sensation of the bladder. Consequently, the patient is un
aware that his or her bladder is full.
Stress urinary incontinence (SUI) occurs when urethral
hypermobility causes leakage in response to increases in intra
abdominal pressure (stress). It is associated with exercise,sneezing,
coughing, lifting or Valsalva. When the urethra is hypermobile, a
pressure differential between the bladder and urethra occurs with
increases in intra-abdominal pressure (stress). This pressure differ
ential overcomes the urethral resistance, producing incontinence.
Instrinsic sphincter deficiency (ISD) is similar to SUI but leakage
occurs with a minimal increase in intra-abdominal pressure and the
urethra is often well supported. ISD should be suspected in-patients
who have persistent incontinence following an incontinence proce
dure.
History
The history should assess the risk factors associated with incon
tinence in an attempt to differentiate which type of incontinence
exists. Pertinent questions include:
• frequency, duration, and timing of UI?
• when do you leak (cough, straining, on the way to the toilet)?
• neurologic problem?
• number and type of pads used per day?
• menopause/hormonal replacement?
• history of previous pelvic, vaginal, or incontinence surgeries?
• constipation and/or encopresis?
• frequent urinary tract infections (UTI)?
• is this condition lifestyle limiting?
• number of pregnancies, deliveries, vaginal vs. c-section?
Urge incontinence is usually preceded by a strong desire to void.
Patients often will complain of having “accidents” on the way to the
toilet. Overflow incontinence typically causes frequent or constant
dribbling as additional urine enters the full bladder. Whereas SIJI
and ISD both present as UI with exertion (increased intra-abdominal
pressure) but differ in that ISD is associated with minimal exertion.
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Physical Examination
A thorough physical examination (PE) of the vagina and the
rectum is performed to rule out atrophic vaginitis and/or neurologi
cal deficit. The anterior vagina is visualized as the patient Valsalvas
with a full bladder to determine the presence of and grade of a
cystocele. A digital rectal examination is performed to determine the
strength of the anal sphincter and the support of the posterior vagina.
A rectocele is herniation of the anterior rectum into the vagina on
Valsalva secondary to decreased posterior vaginal support. The
urethra should be evaluated for hypermobility (Figure 1). A simple
method involves placing a lubricated cotton tipped applicator in the
urethra and have the patient Valsalva. The applicator should initially
be horizontal (supine patient), with Valsalva the applicator should
rotate less than 15°. A rotation greater than 150 is consistent with
urethral hypermobility.
It is important to reproduce the incontinence. First, the urologist
or urogynecologist will catheterize the bladder to determine the
volume of the post-void residual urine. A post-void of greater than
50cc is abnormal. Once catheterized, the bladder is filled and patient
is asked to cough and/or Valsalva. Does the patient leak? Often a
pressure measuring catheter is used to measure the pressure neces
sary to produce UI. This is known as a cystometrogram or
urodynamics. Finally urodynamics are used to determine the com
pliance of the bladder. The non-compliant bladder often presents
with symptoms of urge incontinence. A urinalysis should be per
formed to rule out a urinary tract infection and glucosuria.
The questions to answer on PE are:
• Is the urethra mobile?
• Does the patient have UI with Valsalva or cough?
• Does the patient have other vaginal problems (cystocele, en
terocele, rectocele, atrophic vaginitis)?
Questions to be answered on Urodynamics include:
• Is the bladder compliant?
• At what pressure does the patient leak (Valsalva leak point
pressure)?
Of note, a normal urethra will not leak at any pressure.
Treatment Options
The vast majority of patients with UI can be cured or improved.
The history and PE with urodynamics will allow the clinician to
determine if the UI is secondary to a bladder problem or a urethral
problem, or combination. Bladder problems are generally treated
medically, whereas urethral problems are generally treated surgi
cally.
Bladder problems produce urge incontinence. Diet modification,
decreasing the consumption of bladder irritants such as caffeine
carbonated beverages, spicy foods and artificial sweeteners, are
often helpful. Medications, namely anticholinergics such as
oxybutynin chloride (Ditropan), hyoscyamin, and Tolteradine, are
quite effective at delaying or preventing premature bladder contrac
tions. Behavior modification, such as bladder retraining or timed
voiding, increases the time intervals between voids, and is often
helpful.
Urethral problems are treated primarily with surgery if conserva
tive measures such as Kegel exercise and estrogen replacement have
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Fig 1.—Urethral hypermobility. The arrow indicates direction of pressure
from an activity such as coughing, causing the bladder neckand
urethra to open briefly. Reference3.
IjUcIcle’
Fig 2.—Sling in place, secured to the pubic bone. Reference 3.
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Table 1 .—Typesof Urinary Incontinence
Type Pathopilysiology Signs and Symptoms
Urge Incontinence I Involuntary bladder contractions I Leaks on way to toilet.
Overflow Incontinence • 8ladder overdistention and • Poor utinary stream
leakage because of impaired • Constant ddbblirig
sensory feedback from the bladder. • No sensation of fullness
Stress Udnary
Incontinence(SUI) I Bladder neclurethral I Incontinence with cough,
hyperrnobility sneeze, or Valsalva
lntdnsic Sphincter I Urinaly sphincter failure I Marked incontinence with
Deficiency (lSD) standing, cough, sneezing,
Valsalva
failed. Kegel exercises are designed to strengthen the muscular
support of the bladder, vagina, and rectum. There are three main
categories of surgeries used to treat SUT: retropubic suspensions
(Marshall-Marchetti-Krantz, Burch culposuspension), transvaginal
suspensions (Raz, Stamey, Pereyra), and sling procedures. The goal
of each is correct urethral hypermobility. The most durable of these
procedures is the pubovaginal sling (PVS) procedure. The PVS uses
a thin strip of autologous (rectus fascia or fascia lata) or cadeveric
fascia to create a hammock-like bolstering of the urethra (see Figure
2). The long-term cure rate of PVS is about 83%.
Patients with ISD refractory to Kegels and estrogen replacement
require either PVS or transurethral submucosal collagen injection to
coapt the open urethra. Estrogen replacement increases the vascu
larity of the vaginal mucosa and urethra thereby increasing the
coaptability of the urethra. Collagen injection is usually performed
as an office based procedure under local anesthetic via a urethro
scope. The collagen is injected under the urethral mucosa at the
proximal urethra in an attempt to coapt the urethra.
Summary
Urinary incontinence affects an estimated 13 million Americans
of which 85% are women. It is an embarrassing and lifestyle limiting
condition for which effective treatment is available. Health care
providers should be alert to the signs and symptoms ofUI and pursue
its etiology. Those patients who fail medical therapy, in whom the
etiology for the incontinence is unclear, or those patients with
concomitant cystocele, enterocele, or rectocele, should be referred
to an incontinence specialist.
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